{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T03:58:38Z","timestamp":1649044718085},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/mph.0000000000000454","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T14:39:51Z","timestamp":1446302391000},"page":"e39-e41","source":"Crossref","is-referenced-by-count":1,"title":["Haploidentical Bone Marrow Transplantation With Clofarabine and Busulfan Conditioning for a Child With Multiple Recurrent Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"38","author":[{"given":"Yuki","family":"Aoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiji","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohsuke","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyoshi","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-31-20210209","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2141.2005.05773.x","article-title":"Childhood acute lymphoblastic leukaemia and relapse.","volume":"131","author":"Gaynon","year":"2005","journal-title":"Br J Haematol"},{"key":"R2-31-20210209","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1200\/JCO.2005.03.8554","article-title":". Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.","volume":"24","author":"Jeha","year":"2006","journal-title":"J Clin Oncol"},{"key":"R3-31-20210209","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1182\/blood-2011-08-374710","article-title":". Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.","volume":"118","author":"Hijiya","year":"2011","journal-title":"Blood"},{"key":"R4-31-20210209","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2141.2009.07882.x","article-title":". Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractorymultiple relapsed acute lymphoblastic leukaemia.","volume":"147","author":"Locatelli","year":"2009","journal-title":"Br J Haematol"},{"key":"R5-31-20210209","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1182\/blood-2011-06-358010","article-title":". Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.","volume":"118","author":"Magenau","year":"2011","journal-title":"Blood"},{"key":"R6-31-20210209","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0609.2012.01822.x","article-title":". Clofarabine-containing conditioning regimen for allo-SCT in AMLALL patients: a survey from the Acute Leukemia Working Party of EBMT.","volume":"89","author":"Chevallier","year":"2012","journal-title":"Eur J Haematol"},{"key":"R7-31-20210209","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bbmt.2012.06.010","article-title":". Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.","volume":"18","author":"Kebriaei","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R8-31-20210209","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3324\/haematol.12365","article-title":". Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Childrens Cancer Study Group Study L99-15.","volume":"93","author":"Manabe","year":"2008","journal-title":"Haematologica"},{"key":"R9-31-20210209","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMoa0811036","article-title":". Loss of mismatched HLA in leukemia after stem-cell transplantation.","volume":"361","author":"Vago","year":"2009","journal-title":"N Engl J Med"},{"key":"R10-31-20210209","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood-2009-11-254284","article-title":". Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation.","volume":"115","author":"Villalobos","year":"2010","journal-title":"Blood"},{"key":"R11-31-20210209","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s12185-010-0572-2","article-title":". Pharmacokinetic monitoring is still required for intravenous busulfan in SCT for small children.","volume":"91","author":"Nagasawa","year":"2010","journal-title":"Int J Hematol"},{"key":"R12-31-20210209","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1399-0012.2010.01352.x","article-title":". Feasibility of tacrolimus, methotrexate, and prednisolone as a graft-versus-host disease prophylaxis in non-T-cell-depleted haploidentical hematopoietic stem cell transplantation for children.","volume":"25","author":"Mochizuki","year":"2011","journal-title":"Clin Transplant"},{"key":"R13-31-20210209","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","article-title":". Randomized trial of busulfan vs. total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.","volume":"32","author":"Bunin","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R14-31-20210209","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2000.18.2.340","article-title":". Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.","volume":"18","author":"Davies","year":"2000","journal-title":"J Clin Oncol"},{"key":"R15-31-20210209","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes.","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"key":"R16-31-20210209","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/bmt.2011.224","article-title":". Clofarabine and CY do not yield reliable engraftment of hematopoietic stem cells.","volume":"47","author":"Karch","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"R17-31-20210209","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbmt.2011.10.041","article-title":". Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.","volume":"18","author":"van Besien","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R18-31-20210209","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/bmt.2013.195","article-title":". A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD).","volume":"49","author":"Gossai","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R19-31-20210209","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2004-03-1212","article-title":". Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism.","volume":"104","author":"Ichinohe","year":"2004","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:47:39Z","timestamp":1620964059000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201601000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000454","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}